Updated overall efficacy and safety of selpercatinib in patients with RET fusion-positive non-small-cell lung cancer (NSCLC): LIBRETTO-001 study Meeting Abstract


Authors: Besse, B.; Drillon, A. E.; Solomon, B. J.; Subbiah, V.; Tan, D. S. W.; Park, K.; De Braud, F. G.; Alonso, G.; Wolf, J.; Soldatenkova, V.; Lin, A. K.; French, P.; Goto, K.; Gautschi, O.
Abstract Title: Updated overall efficacy and safety of selpercatinib in patients with RET fusion-positive non-small-cell lung cancer (NSCLC): LIBRETTO-001 study
Meeting Title: Swiss Oncology and Hematology Congress (SOHC)
Journal Title: Swiss Medical Weekly
Volume: 151
Meeting Dates: 2021 Nov 18-20
Meeting Location: Zürich, Switzerland
ISSN: 1424-7860
Publisher: E M H Swiss Medical Publishers Ltd  
Date Published: 2021-11-17
Start Page: w30107
Language: English
ACCESSION: WOS:000760549700059
PROVIDER: wos
PUBMED: 34846116
DOI: 10.4414/smw.2021.w30107
Notes: Meeting Abstract: P34 -- Located on page 34S of the publication -- Supplementum 255 -- MSK author A. E. Drilon's last name is misspelled on the original publication -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    633 Drilon